Pangenotypic

Pangenotypic is an adjective describing something that relates to or is effective across all genotypes of a given organism or pathogen. The term combines pan- meaning all with genotypic, indicating a broad or universal scope across genetic variation within a species. In biology, genotypes refer to the genetic makeup found within individuals of a species, which can vary by strain or subtype.

In diagnostics, pangenotypic tests or assays are designed to detect or characterize infections across all known genotypes, often by targeting conserved genetic regions. This approach can reduce or eliminate the need for genotype-specific testing and streamline laboratory workflows, especially in settings with diverse or unknown genotype distributions.

In therapeutics, a pangenotypic regimen or drug is effective against multiple genotypes of the target pathogen. The best-known example is hepatitis C virus (HCV). Pangenotypic treatments, such as sofosbuvir/velpatasvir and glecaprevir/pibrentasvir, act across all major HCV genotypes (1 through 6) and have contributed to simplified treatment algorithms and broader global access. The concept supports broad-spectrum antiviral strategies and can apply to other pathogens where genotype diversity challenges treatment selection.

In research and vaccine development, pangenotypic approaches aim to elicit protection or response across multiple genotypes, addressing genetic diversity that can undermine genotype-specific interventions. While widely used in virology and infectious disease contexts, the term is used variably and is most prominent in discussions of broad-spectrum diagnostics and therapies.